GCP
PROK icon

GSA Capital Partners’s ProKidney PROK Stock Holding History

GSA Capital Partners’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$615K Buy
301,622
+98,396
+48% +$180K 0.04% 861
2026
Q1 		$364K Buy
203,226
+14,182
+8% +$30.1K 0.02% 1125
2025
Q4 		$423K Buy
189,044
+21,013
+13% +$55.3K 0.04% 931
2025
Q3 		$407K Sell
168,031
-342,584
-67% -$912K 0.03% 990
2025
Q2 		$302K Buy
+510,615
New +$398K 0.02% 1248

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GSA Capital Partners's PROK Position: Q2 2026 in Review

GSA Capital Partners increased its ProKidney (PROK) stake by 48% in Q2 2026, buying an estimated $180K and bringing the position to 301,622 shares worth $615K. The position accounts for 0.04% of the portfolio, ranked #861.

GSA Capital Partners first reported a position in PROK in Q2 2025 and has held it in 5 quarters since. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • GSA Capital Partners held 301,622 shares of ProKidney worth $615K as of Q2 2026.
  • GSA Capital Partners bought 98,396 ProKidney shares in Q2 2026, an estimated $180K.
  • ProKidney made up 0.04% of GSA Capital Partners's portfolio in Q2 2026, its #861 holding.
  • GSA Capital Partners first reported a position in ProKidney in Q2 2025 and has held it in 5 quarters since.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.